Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcal glucosyltransferases (GTFs) and adhesion-related structures are primary virulence factors of cariogenic bacteria, particularly Streptococcus mutans, essential for the formation of dental plaque (Bowen & Koo, 2011). GTFs are extracellular enzymes that synthesize sticky glucan polymers from dietary sucrose, providing the physical matrix for biofilm development and facilitating bacterial accumulation on teeth (Krzyściak et al., 2014). Adhesion-related structures, such as the Antigen I/II (AgI/II) protein family, mediate the initial, high-affinity binding of streptococci to the salivary pellicle coating the tooth surface (Ma et al., 2015). By targeting these components, therapeutic agents aim to prevent the establishment of pathogenic biofilms and the subsequent localized acid production that causes tooth decay. Current pharmacological approaches include the use of monoclonal antibodies like CaroRx to block adhesion and small-molecule inhibitors or natural polyphenols to disrupt GTF activity (Lynch, 2011). These "anti-virulence" strategies are advantageous as they reduce the pathogenicity of the oral flora without the selective pressure for antibiotic resistance associated with traditional bactericidal agents.
Inhibition of glucosyltransferase enzyme activity to prevent glucan synthesis and blocking of adhesion-related proteins to prevent bacterial attachment to the salivary pellicle.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcal glucosyltransferase and adhesion-related structures (GTF/AgI/II).